SCHEMBL21481644

SCHEMBL21481644

c1ccc(-n2c3ccccc3c3cc4c(cc32)c2ccccc2n4-c2ccc3c(c2)c2ccccc2n3-c2ccc3c(c2)oc2ccccc23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
ATM Q13315 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
AHR P35869 2/20 0.41
PTGER4 P35408 1/20 0.40
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
MAPT P10636 4/20 0.40
ALDH1A1 P00352 4/20 0.40
HPGD P15428 3/20 0.40
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35
POLB P06746 1/20 0.35
BRCA1 P38398 1/20 0.35
TTR P02766 1/20 0.35
PTPN1 P18031 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17228184 0.97 KDM4E (0.53) KDM4EATML3MBTL1AHRPTGER4
SCHEMBL27427687 0.96 KDM4E (0.49) KDM4EATML3MBTL1AHRPTGER4
SCHEMBL27428588 0.96 KDM4E (0.51) KDM4EATML3MBTL1AHRPTGER4
SCHEMBL17245948 0.94 KDM4E (0.50) KDM4EATML3MBTL1AHRPTGER4
SCHEMBL16171188 0.94 KDM4E (0.50) KDM4EATML3MBTL1AHRPTGER4
SCHEMBL21481277 0.93 KDM4E (0.46) KDM4EATML3MBTL1AHRPTGER4
SCHEMBL9890220 0.93 KDM4E (0.51) KDM4EATML3MBTL1AHRPTGER4
SCHEMBL17245429 0.93 KDM4E (0.51) KDM4EATML3MBTL1AHRPTGER4
SCHEMBL27428318 0.93 KDM4E (0.51) KDM4EATML3MBTL1AHRPTGER4
SCHEMBL24357013 0.93 AHR (0.46) KDM4EATML3MBTL1AHRPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) 2023-11-09 US disclosed
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) 2019-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190319197-A1 ORGANIC COMPOUND, APPLICATIONS THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE PIEZO1, OR10J3, OR51E2 KDM4E 2904/4885ATM 2334/4885L3MBTL1 1968/4885
US-20230363270-A1 ORGANIC COMPOUNDS, ORGANIC MIXTURES AND THE USES THEREOF AOX1, ODC1, OTC KDM4E 4036/4885ATM 2511/4885L3MBTL1 2702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.